2015•Practical Journal of Medicine & PharmacyRequires access

The changes of platelet aggregation ratio in acute coronary syndrome patients with clopigogrel resistance following alternated by ticagrelor

Meilin Li

Open publisher page 0 citations

Abstract

Objective To observe the variance of the platelet aggregation ratio after using ticagrelor for instead of clopidogrel in acute coronary syndrome patients suffering from clopidogrel resistance,Methods Platelet aggregation ratio test induced by adenosine diphosphate(ADP) identified acute coronary syndrome patients with clopidogrel resistance underwent the PCI(percutaneous coronary intervention) from July 2013 to July 2014,The 57 patients with clopidogrel resistance were given 180 mg ticagrelor load followed by 90 mg twice daily maintenance therapy,for instead of clopidogrel 75 mg once daily for 1 month,and the platelet aggregation ratio were tested.Results Platelet aggregation rate had significant difference(P0.05) statistically after administration of ticagrelor compared with clopidogrel,Conclusion Compared with the regular-dose treatment of clopidogrel,ticagrel can effectively decrease the platelet aggregation ratio in acute coronary syndrome patients with clopidogrel resistance.

About this research paper

What this paper is about

Objective To observe the variance of the platelet aggregation ratio after using ticagrelor for instead of clopidogrel in acute coronary syndrome patients suffering from clopidogrel resistance,Methods Platelet aggregation ratio test induced by adenosine diphosphate(ADP) identified acute coronary syndrome patients with clopidogrel resistance underwent the PCI(percutaneous coronary intervention) from July 2013 to July 2014,The 57 patients with clopidogrel resistance were given 180 mg ticagrelor load followed by 90 mg twice daily maintenance therapy,for instead of clopidogrel 75 mg once daily for 1 month,and the platelet aggregation ratio were tested.Results Platelet aggregation rate had significant difference(P0.05) statistically after administration of ticagrelor compared with clopidogrel,Conclusion Compared with the regular-dose treatment of clopidogrel,ticagrel can effectively decrease the platelet aggregation ratio in acute coronary syndrome patients with clopidogrel resistance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the variance of the platelet aggregation ratio after using ticagrelor for instead of clopidogrel in acute coronary syndrome patients suffering from clopidogrel resistance,Methods Platelet aggregation ratio test induced by adenosine diphosphate(ADP) identified acute coronary syndrome patients with clopidogrel resistance underwent the PCI(percutaneous coronary intervention) from July 2013 to July 2014,The 57 patients with clopidogrel resistance were given 180 mg ticagrelor load followed by 90 mg twice daily maintenance therapy,for instead of clopidogrel 75 mg once daily for 1 month,and the platelet aggregation ratio were tested.Results Platelet aggregation rate had significant difference(P0.05) statistically after administration of ticagrelor compared with clopidogrel,Conclusion Compared with the regular-dose treatment of clopidogrel,ticagrel can effectively decrease the platelet aggregation ratio in acute coronary syndrome patients with clopidogrel resistance.

Key concepts: Ticagrelor, Clopidogrel, Medicine, Acute coronary syndrome, Percutaneous coronary intervention, Internal medicine, Cardiology, P2Y12

Related papers

Back to paper searchBrowse research topicsOriginal source
The changes of platelet aggregation ratio in acute coronary syndrome patients with clopigogrel resistance following alternated by ticagrelor — Research Paper | ScholarLens